Back
ESC2025 Premium Access

Quantifying the impact of real-world evidence: the sacubitril/valsartan experience

Session: Epidemiology, prognosis, and outcome in chronic heart failure (3)
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor S. Rathore (Kankakee, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Saif Rathore

Sandbar Life Sciences, Kankakee (United States of America)
0 follower

3 more presentations in this session

In patients with heart failure with unplanned admission to hospital lack of improvement in quality-of-life 2 months after discharge identifies individuals at very high risk of readmission or death.

Speaker: Mrs M. Mcginlay (Leeds, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of severe mitral regurgitation on patients with 'De Novo' heart failure and reduced ejection fraction: baseline characteristics and survival analysis

Speaker: Mr M. Mejuto Blanco (Santiago de Compostela, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Heart rate control in heart failure: insights from nationwide multicenter registry HEROES.

Speaker: Professor J. Kasprzak (Lodz, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Epidemiology, prognosis, and outcome in chronic heart failure (3)

Speakers: Doctor S. Rathore, Mrs M. Mcginlay, Mr M. Mejuto Blanco, Professor J. Kasprzak
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources